{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:08:53Z","timestamp":1773814133037,"version":"3.50.1"},"reference-count":24,"publisher":"Jaypee Brothers Medical Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.59556\/japi.72.0678","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:46:33Z","timestamp":1752227193000},"page":"40-42","source":"Crossref","is-referenced-by-count":2,"title":["Fixed-dose Combination of Torsemide and Mineralocorticoid Receptor Antagonists"],"prefix":"10.59556","volume":"72","author":[{"given":"Sunip","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish B","family":"Navasundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agam","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaspal","family":"Arneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Jaswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumaresan","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishwa Bhushan","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendar Narayan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnanand","family":"Aila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Zalte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20250711094627_B1","doi-asserted-by":"crossref","first-page":"41\u2013","DOI":"10.2152\/jmi.70.41","article-title":"Benefits of guideline-directed medical therapy to loop diuretics in management of heart failure.","volume":"70:","author":"Kusunose","year":"2023;","journal-title":"J Med Invest"},{"key":"key20250711094627_B2","unstructured":"Kanderi T, Vaitla P. Torsemide. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [updated 2023 Jul 3; cited 2024 Jul 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559175\/"},{"issue":"(4):","key":"key20250711094627_B3","doi-asserted-by":"crossref","first-page":"235\u2013","DOI":"10.14797\/mdcj-11-4-235","article-title":"Mineralocorticoid receptor antagonists for treatment of hypertension and heart failure.","volume":"11","author":"Sica","year":"2015;","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"(5):","key":"key20250711094627_B4","doi-asserted-by":"crossref","first-page":"605\u2013","DOI":"10.1517\/14656566.2014.879117","article-title":"Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents.","volume":"15","author":"Tamargo","year":"2014;","journal-title":"Expert Opin Pharmacother"},{"key":"key20250711094627_B5","doi-asserted-by":"crossref","first-page":"185\u2013","DOI":"10.1038\/hr.2012.182","article-title":"Mineralocorticoid receptor antagonists: their use and differentiation in Japan.","volume":"36:","author":"Sato","year":"2013;","journal-title":"Hypertens Res"},{"issue":"(3):","key":"key20250711094627_B6","doi-asserted-by":"crossref","first-page":"331\u2013","DOI":"10.2337\/cd21-0050","article-title":"Finerenone.","volume":"39","author":"Marcath","year":"2021;","journal-title":"Clin Diabetes"},{"key":"key20250711094627_B7","doi-asserted-by":"crossref","first-page":"105859.","DOI":"10.1016\/j.phrs.2021.105859","article-title":"Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders - new perspectives for combination therapy.","volume":"172:","author":"Kolkhof","year":"2021;","journal-title":"Pharmacol Res"},{"issue":"(13):","key":"key20250711094627_B8","doi-asserted-by":"crossref","first-page":"e029071.","DOI":"10.1161\/JAHA.122.029071","article-title":"Eligibility for the 4 pharmacological pillars in heart failure with reduced ejection fraction at discharge.","volume":"12","author":"D\u2019Amario","year":"2023;","journal-title":"J Am Heart Assoc"},{"key":"key20250711094627_B9","doi-asserted-by":"crossref","first-page":"92\u2013","DOI":"10.1016\/j.ijcard.2017.03.051","article-title":"Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: a 1-year follow-up study.","volume":"238:","author":"Rinkuniene","year":"2017;","journal-title":"Int J Cardiol"},{"issue":"(1):","key":"key20250711094627_B10","doi-asserted-by":"crossref","first-page":"5\u2013","DOI":"10.1097\/MJT.0b013e31813e6452","article-title":"Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.","volume":"16","author":"Kumar","year":"2009;","journal-title":"Am J Ther"},{"issue":"(2):","key":"key20250711094627_B11","doi-asserted-by":"crossref","first-page":"236\u2013","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.","volume":"53","author":"L\u00f3pez","year":"2009;","journal-title":"Hypertension"},{"issue":"(Suppl 2):","key":"key20250711094627_B12","first-page":"S19.","article-title":"Current practice and perceptions on the screening, diagnosis and use of mineralocorticoid receptor antagonist in heart failure.","volume":"2","author":"Sonawala","year":"2023;","journal-title":"Int J Diabetes Technol"},{"issue":"(9):","key":"key20250711094627_B13","doi-asserted-by":"crossref","first-page":"e73737.","DOI":"10.1371\/journal.pone.0073737","article-title":"The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.","volume":"8","author":"Gravez","year":"2013;","journal-title":"PLoS One"},{"key":"key20250711094627_B14","doi-asserted-by":"crossref","first-page":"S53.","DOI":"10.1016\/j.ihj.2023.11.111","article-title":"Rationale and study design of real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, longitudinal, multicentre, observational study.","volume":"75:","author":"Ponde","year":"2023;","journal-title":"Indian Heart J"},{"key":"key20250711094627_B15","doi-asserted-by":"crossref","first-page":"104861.","DOI":"10.1016\/j.microc.2020.104861","article-title":"Simultaneous micro-determination of eplerenone and torsemide in their combined tablets using HPTLC-Dual wavelength spectrodensitometric and spectrophotometric methods.","volume":"156:","author":"Sameh","year":"2020;","journal-title":"Microchem J"},{"key":"key20250711094627_B16","doi-asserted-by":"crossref","first-page":"19\u2013","DOI":"10.53411\/jpadr.2020.1.1.5","article-title":"Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide.","volume":"1:","author":"Melcy","year":"2020;","journal-title":"JPADR"},{"issue":"(1):","key":"key20250711094627_B17","first-page":"31\u2013","article-title":"Spironolactone + torsemide induced Stevens-Johnson syndrome.","volume":"1","author":"Patel","year":"2021;","journal-title":"J Heal Sci Prof Educ"},{"key":"key20250711094627_B18","unstructured":"Aldactone Prescribing Information. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/012151s075lbl.pdf. Last accessed on 19 June, 2024."},{"key":"key20250711094627_B19","unstructured":"Aldactone. Available at: https:\/\/www.pfizermedicalinformation.com\/aldactone\/dosage-admin. Last accessed on 19 June, 2024."},{"key":"key20250711094627_B20","unstructured":"About eplerenone. Available at: https:\/\/www.nhs.uk\/medicines\/eplerenone\/about-eplerenone\/. Last accessed on 19 June, 2024."},{"key":"key20250711094627_B21","unstructured":"How and when to take eplerenone. Available at: https:\/\/www.nhs.uk\/medicines\/eplerenone\/how-and-when-to-take-eplerenone\/. Last accessed on 19 June, 2024."},{"key":"key20250711094627_B22","unstructured":"CDSCO. Available at: https:\/\/cdscoonline.gov.in\/CDSCO\/. CDSCO. Available at: https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs. Last accessed on 19 June, 2024."},{"issue":"(6):","key":"key20250711094627_B23","first-page":"347\u2013","article-title":"Hypokalaemic quadriparesis following torsemide and spironolactone use.","volume":"31","author":"Kaur","year":"2018;","journal-title":"Natl Med J India"},{"issue":"(12):","key":"key20250711094627_B24","doi-asserted-by":"crossref","first-page":"1673\u2013","DOI":"10.1007\/s40262-023-01312-9","article-title":"The pharmacokinetics of the nonsteroidal mineralocorticoid receptor antagonist finerenone.","volume":"62","author":"Heinig","year":"2023;","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:46:36Z","timestamp":1752227196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-9-s1-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.59556\/japi.72.0678"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0678","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}